Mezigdomide Combinations Show Promise in Multiple Myeloma

(MedPage Today) -- The phase I/II CA057-003 trial presented at the American Society of Hematology annual meeting showed promising results with novel mezigdomide-based combinations in relapsed or refractory multiple myeloma.
In this exclusive MedPage...